37.Issue 04 april 26 - INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Volume : 13, Issue : 04, April – 2026

Title:

3D PRINTING TECHNOLOGIES USED IN PHARMA

Authors :

Ms. Shinde Amruta Nilesh and Miss. Shirke S.S

Abstract :

Three-dimensional (3D) printing has emerged as a transformative manufacturing technology in the pharmaceutical field, enabling the production of personalized, precise, and complex drug dosage forms. Various 3D printing techniques— including fused deposition modeling (FDM), stereolithography (SLA), selective laser sintering (SLS), inkjet printing, binder jetting, and semi-solid extrusion— allow controlled deposition of materials to fabricate patient-specific medicines with tailored dose, release kinetics, and geometry. These techniques support innovations such as polypills, rapid-dissolving tablets, modified-release systems, and implants. The first FDA-approved 3D-printed drug, Spritam®, demonstrated the clinical relevance of this technology. Advantages include on-demand manufacturing, high customization, and improved therapeutic outcomes. However, challenges such as limited pharmaceutical-grade printable materials, regulatory uncertainties, scale-up issues, and quality-control requirements continue to restrict widespread adoption. Overall, 3D printing represents a promising platform for advancing personalized medicine and redefining pharmaceutical manufacturing.
Keywords :-3D printing, Additive manufacturing, Personalized medicine, Fused deposition modeling (FDM), Stereolithography (SLA), Digital light processing (DLP), Selective laser sintering (SLS), Inkjet printing, Binder jetting, Semi-solid extrusion.

Cite This Article:

Please cite this article in press Amruta Nilesh Shinde et al., 3D Printing Technologies Used In Pharma., Indo Am. J. P. Sci, 2026; 13(04).

REFERENCES:

1. Hull CW. Apparatus for production of three-dimensional objects by stereolithography. U.S. Patent 4,575,330 (1986).
2. Gibson I, Rosen D, Stucker B. Additive Manufacturing Technologies. Springer; 2015.
3. Lipson H, Kurman M. Fabricated: The New World of 3D Printing. Wiley; 2013.
4. Katstra WE, Rowe CW, et al. Oral dosage forms fabricated by 3D printing. Pharm Res. 2000;17(10):1206-1212.
5. Rowe CW, et al. Printing of drug delivery devices. J Control Release. 2000;66(1):11-17.
6. Norman J, Madurawe RD, et al. A review of 3D printing technologies for pharmaceutical applications. J Pharm Sci. 2017;106(1):1-17.
7. Alhnan MA, et al. Emergence of 3D-printed dosage forms. Pharm Res. 2016;33(8):1817- 1832.
8. Melocchi A, et al. 3D printing in pharmaceutics: materials and technologies. Adv Drug Deliv Rev. 2020;153:116-143.
9. ASTM International. ASTM F2792 – Standard Terminology for Additive Manufacturing Technologies. ASTM; 2012.
10. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793-795.
11. Awad A, Trenfield SJ, et al. 3D printing in personalized medicine. Adv Drug Deliv Rev. 2021;173:310-331.
12. UK Government. Genome UK: The Future of Healthcare. 2020.13. Prasad LK, Smyth H. 3D printing technologies in personalized drug delivery. Drug Dev Ind Pharm. 2020;46(9):1443-1456
13. Prasad, L. K., & Smyth, H. (2020). 3D printing technologies and their role in pharmaceutical development. Drug Development and Industrial Pharmacy, 46(9), 1443–1456.
14. U.S. Food and Drug Administration (FDA). (2015). FDA approves the first 3D printed drug.
15. Prasad LK, Smyth H. “3D Printing technologies for drug delivery applications.” Drug Dev Ind Pharm, 2016.
16. Konta A, García-Piña M, Serrano DR. “Personalised 3D printed medicines: principles and current applications.” Int J Pharm, 2020.
17. Sadia M et al. “Adaptation of pharmaceutical excipients to FDM 3D printing for drug delivery.” Eur J Pharm Biopharm, 2018.
18. Jamróz W, Szafraniec J, Kurek M, Jachowicz R. “3D printing in pharmaceutical and medical applications.” Pharm Res, 2018.
19. Park B et al. “3D printing of oral solid dosage forms.” J Pharm Sci, 2019.
20. A. Melocchi et al., “Fused deposition modeling (FDM) technique for the production of oral drug delivery systems,” International Journal of Pharmaceutics, 2016.
21. M. A. Goyanes et al., “3D printing of modified-release oral tablets using FDM,” Journal of Controlled Release, 2015.
22. Z. R. Alqahtani et al., “Pharmaceutical applications of fused deposition modeling (FDM) 3D printing,” Pharmaceutics, 2021.
23. G. K. Eleftheriadis & D. Fatouros, “3D printing applications in pharmaceutical formulation and drug delivery,” Pharmaceutics, 2020.
24. Sadia et al., “Hot-melt extrusion and FDM: a new tool for personalized medicines,” Advanced Drug Delivery Reviews, 2018.
25. Ventola, C. L. “Medical Applications of 3D Printing.” P&T, 2014.
26. Konta, A. et al., “3D printing for drug delivery: technologies and challenges.” Drug Discovery Today, 2017.
27. Goyanes, A. et al. “Stereolithography for pharmaceutical applications.” International Journal of Pharmaceutics, 2015.
28. Robles-Martinez, P. et al. Additive Manufacturing, 2020.
29. Gross, B. C. et al. “Evaluation of 3D printing technologies.” Journal of Materials Processing Technology, 2014.
30. Wang, J. et al. “Pharmaceutical 3D printing.” Journal of Pharmaceutical Sciences, 2017.
31. Elbadawi, M. et al. “DLP 3D printing for pharmaceuticals.” International Journal of Pharmaceutics, 2020.
32. Martinez, P. R. et al. “Photopolymer systems for drug delivery.” Advanced Drug Delivery Reviews, 2021.
33. JOURNAL OF MECHANICS OF CONTINUA AND MATHEMATICAL SCIENCES
34. Progress in Additive Manufacturing
35. Deckard, C. R. Selective Laser Sintering (SLS) Technology. University of Texas at Austin, 1989.
36. Awad, A., Fina, F., Goyanes, A., et al. “3D Printing: Principles and Pharmaceutical Applications.” International Journal of Pharmaceutics, 2017.
37. Campbell, I., Bourell, D., & Gibson, I. “Additive Manufacturing: Rapid Prototyping Comes of Age.” Rapid Prototyping Journal, 2012.
38. Nayak, A., & Goel, H. “Selective Laser Sintering in Pharmaceutical Product Development.” European Journal of Pharmaceutical Sciences, 2018.
39. Trenfield, S. J., Awad, A., Goyanes, A., et al. “Pharmaceutical Applications of SLS 3D Printing.” International Journal of Pharmaceutics, 2019.
40. Fina, F., Goyanes, A., Rowland, M., et al. “Engineering Drug Release Profiles Using SLS 3D Printing.” Eur. J. Pharmaceutics & Biopharmaceutics, 2018.
41. https://5.imimg.com/data5/XB/YE/RX/SELLER-51687494/selective-laser-sintering- service-1000×1000.jpg
42. ISO/ASTM 52900 (2021). Additive manufacturing — General principles — Terminology (Binder Jetting Section).
43. Hsiao, W. K., Lorber, B., Reitsamer, H., & Khinast, J. G. (2010). “Inkjet printing of pharmaceuticals.” Journal of Pharmaceutical Sciences, 99(8), 3464–3475.
44. Wu, C. Y., & Yang, X. (2018). “Research advances in Drop-on-Demand inkjet printing for drug delivery.” Advanced Drug Delivery Reviews, 132, 104–114.
45. Book: “Inkjet Technology for Digital Fabrication” (Ed. Ian M. Hutchings & Graham D. Martin, 2012).
46. Rowe et al.,2012,Handbook of Pharmaceutical Excipients
47. Skowyra et al.,2015,International Journal of Pharmaceutics
48. Hutchings & Martin, 2012, Inkjet Technology for Digital Fabrication.
49. Derby, 2010, Annual Review of Materials Research.
50. https://www.researchgate.net/publication/379151302/figure/fig16/AS:1143128128035384 9@1727376156561/Schematic-diagram-of-binder-jetting-BJ.png
51. https://www.researchgate.net/publication/340675351/figure/fig1/AS:11431281119137782 @1676024183702/Schematic-illustration-of-drop-on-demand-inkjet-printing-process-a- piezoelectric-DOD.ppm
52. Goyanes, A., et al. International Journal of Pharmaceutics, 2019 – Review of SSE 3D printing.
53. Jamróz, W., et al. Journal of Controlled Release, 2018 – PAM mechanism in pharmaceutical printing.
54. Araújo, M., et al. Materials Science and Engineering C, 2020 – Solidification mechanisms in SSE.
55. Khaled, S.A., et al. International Journal of Pharmaceutics, 2015 – Formulation preparation for SSE.
56. Trenfield, S.J., et al. Pharmaceutics, 2018 – Cartridge and microsyringe systems.
57. Seoane-Viaño, I., et al. Advanced Drug Delivery Reviews, 2021 – Controlled extrusion in SSE 3D printing.
58. Goyanes, A., et al. Additive Manufacturing, 2018 – Layer-by-layer construction in SSE.
59. Araújo, M. & Serra, A. Materials Science & Engineering C, 2020 – Post-processing and curing.
60. Jamróz, W., et al. Pharmaceutical Research, 2017 – Low-temperature benefits.
61. Khaled, S.A., Burley, J.C., et al. International Journal of Pharmaceutics, 2015 – High drug loading in SSE.
62. Seoane-Viaño, I., et al. Journal of Pharmaceutical Sciences, 2020 – Material compatibility.
63. Goyanes, A., et al. Pharmaceutics, 2020 – Personalised dosing with SSE.
64. Trenfield, S.J., et al. 3D Printing in Medicine, 2019 – Mechanical limitations.
65. Jamróz, W., et al. European Journal of Pharmaceutical Sciences, 2017 – Resolution limits.
66. Araújo, M., et al. Drug Development and Industrial Pharmacy, 2020 – Rheology and printability.
67. Seoane-Viaño, I., et al. Advanced Drug Delivery Reviews, 2021 – Time and drying limitations.
68. Cho, S. et al. (2019). Electrohydrodynamic jet printing for pharmaceutical micro- fabrication. Advanced Drug Delivery Reviews, 146, 37–52.
69. Park, J. U. et al. (2007). High-resolution EHD printing of polymer inks. Nature Materials, 6, 782–789.
70. Raut, S. et al. (2023). Emerging EHD-based 3D printing for controlled drug delivery. International Journal of Pharmaceutics, 631, 122571.
71. Onses, M. S. et al. (2015). Mechanisms of nanostructure formation in E-jet printing. Advanced Materials, 27, 693–705.
72. Maruo, S., Nakamura, O., & Kawata, S. (1997). Three-dimensional microfabrication using two-photon-absorbed photopolymerization. Optics Letters, 22(2), 132–134.
73. Malinauskas, M. et al. (2013). 3D micro- and nano-structuring via 2PP for biomedical applications. Laser & Photonics Reviews, 7(5), 681–711.
74. Kumi, G. et al. (2010). 2PP for rapid microfabrication of biodegradable medical devices. Advanced Materials, 22(9), 929–932.
75. Farsari, M. & Chichkov, B. N. (2009). 2PP microfabrication for bio-applications. Nature Photonics, 3, 450–452.
76. Su, S.; Liang, J.; Wang, Z.; Xin, W.; Li, X.; Wang, D. Microtip focused electrohydrodynamic jet printing with nanoscale resolution. Nanoscale, 2020, 12, 24450– 24462. DOI: 10.1039/D0NR08236H
77. https://ars.els-cdn.com/content/image/1-s2.0-S2214860423000878-gr1.jpg
78. Melocchi, A., et al. (2020). 3D printing in oral drug delivery. Advanced Drug Delivery Reviews, 159, 28–48.
79. Aprecia Pharmaceuticals. (2015). FDA approval of Spritam® — first 3D-printed drug.
80. Khaled, S. A., et al. (2014). 3D printing of a five-in-one polypill. Journal of Controlled Release, 217, 308–314.
81. Goyanes, A., et al. (2014). 3D printing of personalized pediatric doses. International Journal of Pharmaceutics, 476, 88–92.
82. Chia, H. N., & Wu, B. M. (2015). Recent advances in 3D printing of biomaterials. Journal of Biological Engineering, 9, 4.
83. https://www.google.com/url?sa=i&url=https%3A%2F%2Flink.springer.com%2Farticle%2 F10.1007%2Fs40964-020-00127-
5&psig=AOvVaw3ovefwlNGmef_q2k8mzk_3&ust=1764002855024000&source=images&c d=vfe&opi=89978449&ved=0CBUQjRxqFwoTCPDLpfPciJEDFQAAAAAdAAAAABAE
84. Awad, A., et al. (2021). 3D printing at point-of-care. Drug Discovery Today, 26, 53–64.
85. Tappa, K., & Jammalamadaka, U. (2018). 3D printing in clinical medicine. Materials Today, 21, 746–756.